Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease

Febuxostat is a nonpurine xanthine oxidase (XO) inhibitor, which recently received marketing approval. However, information regarding the experience with this agent among advanced chronic kidney disease (CKD) patients is limited. In the current study, we investigated the effects of oral febuxostat i...

Descripción completa

Detalles Bibliográficos
Autores principales: Akimoto, Tetsu, Morishita, Yoshiyuki, Ito, Chiharu, Iimura, Osamu, Tsunematsu, Sadao, Watanabe, Yuko, Kusano, Eiji, Nagata, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2014
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134003/
https://www.ncbi.nlm.nih.gov/pubmed/25210423
http://dx.doi.org/10.4137/DTI.S16524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4134003/
https://www.ncbi.nlm.nih.gov/pubmed/25210423
http://dx.doi.org/10.4137/DTI.S16524

Ejemplares similares